157 related articles for article (PubMed ID: 32042274)
21. Can we shorten the overall treatment time in postoperative brachytherapy of endometrial carcinoma? Comparison of two brachytherapy schedules.
Rovirosa A; Ascaso C; Arenas M; Sabater S; Herreros A; Camarasa A; Rios I; Holub K; Pahisa J; Biete A
Radiother Oncol; 2015 Jul; 116(1):143-8. PubMed ID: 26194144
[TBL] [Abstract][Full Text] [Related]
22. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
23. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
[TBL] [Abstract][Full Text] [Related]
24. Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma.
Sunil RA; Bhavsar D; Shruthi MN; Kunikullaya US; Vyas RK; Parikh A; Mehta MJ; Patel PN
J Contemp Brachytherapy; 2018 Apr; 10(2):105-114. PubMed ID: 29789759
[TBL] [Abstract][Full Text] [Related]
25. Vaginal cuff brachytherapy practice in endometrial cancer patients: a report from the Turkish Oncology Group.
Bolukbasi Y; Onal C; Ozsaran Z; Senyurek S; Akdemir EY; Selek U; Yıldız F
J Contemp Brachytherapy; 2021 Apr; 13(2):152-157. PubMed ID: 33897788
[TBL] [Abstract][Full Text] [Related]
26. Stages I-III Inoperable Endometrial Carcinoma: A Retrospective Analysis by the Gynaecological Cancer GEC-ESTRO Working Group of Patients Treated with External Beam Irradiation and 3D-Image Guided Brachytherapy.
Rovirosa Á; Zhang Y; Tanderup K; Ascaso C; Chargari C; Van der Steen-Banasik E; Wojcieszek P; Stankiewicz M; Najjari-Jamal D; Hoskin P; Han K; Segedin B; Potter R; Van Limbergen E;
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835443
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer.
Tétreault-Laflamme A; Nguyen-Huynh TV; Carrier JF; Samouëlian V; Sauthier P; Beauchemin MC; Barkati M
Int J Gynecol Cancer; 2016 Feb; 26(2):301-6. PubMed ID: 26745699
[TBL] [Abstract][Full Text] [Related]
28. Multichannel vaginal cylinder brachytherapy-Impact of tumor thickness and location on dose to organs at risk.
Glaser SM; Kim H; Beriwal S
Brachytherapy; 2015; 14(6):913-8. PubMed ID: 26412618
[TBL] [Abstract][Full Text] [Related]
29. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
[TBL] [Abstract][Full Text] [Related]
30. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
[TBL] [Abstract][Full Text] [Related]
31. Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society.
Harkenrider MM; Grover S; Erickson BA; Viswanathan AN; Small C; Kliethermes S; Small W
Brachytherapy; 2016; 15(1):23-9. PubMed ID: 26620818
[TBL] [Abstract][Full Text] [Related]
32. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.
Harkenrider MM; Block AM; Alektiar KM; Gaffney DK; Jones E; Klopp A; Viswanathan AN; Small W
Brachytherapy; 2017; 16(1):95-108. PubMed ID: 27260082
[TBL] [Abstract][Full Text] [Related]
33. Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies.
Murakami N; Kasamatsu T; Sumi M; Yoshimura R; Harada K; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Itami J
Radiat Oncol; 2014 Jan; 9():31. PubMed ID: 24456669
[TBL] [Abstract][Full Text] [Related]
34. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?
Greven KM; D'Agostino RB; Lanciano RM; Corn BW
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):101-4. PubMed ID: 9747826
[TBL] [Abstract][Full Text] [Related]
35. One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients.
De Sanctis V; Musio D; De Felice F; Marampon F; Valeriani M; Bonome P; Anzellini D; Facondo G; Vullo G; Massaro M; Di Staso M; Bonfili P; Chalaszczyk A; Gravina GL; Tombolini V; Osti MF
J Contemp Brachytherapy; 2020 Apr; 12(2):124-130. PubMed ID: 32395136
[TBL] [Abstract][Full Text] [Related]
36. Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
Westerveld H; de Leeuw A; Kirchheiner K; Dankulchai P; Oosterveld B; Oinam A; Hudej R; Swamidas J; Lindegaard J; Tanderup K; Pötter R; Kirisits C;
Radiother Oncol; 2016 Sep; 120(3):420-427. PubMed ID: 27237058
[TBL] [Abstract][Full Text] [Related]
37. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
[TBL] [Abstract][Full Text] [Related]
38. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
39. Modified Houdek vault applicator for high-dose-rate brachytherapy: a technical report and case series.
Krishnamurthy R; Gurram L; Ghadi Y; Aravindhan D; Scaria L; Kohle S; Kadam S; Chopra S; Mahantshetty U
J Contemp Brachytherapy; 2021 Dec; 13(6):649-654. PubMed ID: 35079251
[TBL] [Abstract][Full Text] [Related]
40. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
